23andMe, Genentech Partner on Parkinson’s
Tracy Vence | Jan 7, 2015
Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.
Breast Cancer Drug Not Safe, Says FDA
Megan Scudellari | Jun 30, 2011
Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.